Highland Global Allocation Fund

Highland Global Allocation Fund announced a trustee reallocation following a death and approved updated governance documents clarifying shareholder rights and board procedures.

NexPoint Funds I has secured a blanket bond with a limit of liability of $6,025,000 to protect against various risks including fraud, forgery, and computer security breaches.

Ethan Powell, a director of Highland Global Allocation Fund, reported the acquisition of 6,750 shares of common stock on June 28, 2024.

Highland Global Allocation Fund is soliciting proxies for its 2026 Annual Meeting of Shareholders, scheduled for June 16, 2026, to elect Dr. Bob Froehlich as a Class II Trustee.

Highland Global Allocation Fund is soliciting proxies for its 2025 Annual Meeting of Shareholders to elect two Class I Trustees.

Highland Global Allocation Fund announces its annual shareholder meeting to be held on June 26, 2024, to elect a Class III Trustee and discuss other business matters.

Raymond James & Associates has filed a Schedule 13G, revealing beneficial ownership of 2,225,124.67 shares, representing 9.5% of the common stock in Highland Global Allocation Fund.

Raymond James & Associates has reported beneficial ownership of 2,353,160.53 common shares, representing 10.1% of the class, in the Highland Global Allocation Fund as of March 31, 2026.

Highland Global Allocation Fund, NexPoint Asset Management, L.P., and James D. Dondero report a complete divestment of their beneficial ownership in Teucrium Commodity Trust.

Raymond James & Associates has reported a 9.7% beneficial ownership stake in Highland Global Allocation Fund, holding over 2.25 million shares.